Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|May 7, 2021
Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case SeriesShuang Zhao, Xinghong Xian, Panwen Tian, et al.
Plos One|August 25, 2025
Diagnostic accuracy of circulating tumor DNA for detection of ALK rearrangement in lung cancer: A systematic review and meta-analysis of 14 studiesJiantong Sun, Lan Yang, Dan Liu, et al.
Annals of Palliative Medicine|April 9, 2021
A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case reportHao Zeng, Yujie Liu, Weiya Wang, et al.
Plos One|December 3, 2016
Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary TuberculosisFaming Jiang, Weiwei Huang, Ye Wang, et al.
Medicine|December 5, 2023
The clinical features and prognosis of fungal pleural infection: A case series and literature reviewYawan Jing, Qi Wei, Hao Zeng, et al.
The Clinical Respiratory Journal|September 19, 2023
Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusionTianyuan Li, Panwen Tian, Qin Huang, et al.
Biomolecules|June 28, 2023
High PD-L1 Expression Correlates with an Immunosuppressive Tumour Immune Microenvironment and Worse Prognosis in ALK-Rearranged Non-Small Cell Lung CancerXia Tian, Yalun Li, Qin Huang, et al.
Annals of Translational Medicine|November 26, 2020
A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patientsJun Shao, Chengdi Wang, Jingwei Li, et al.
Frontiers in Oncology|September 6, 2021
Case Report: Identification of Two Rare Fusions, PDK1-ALK and STRN-ALK, That Coexist in a Lung Adenocarcinoma Patient and the Response to AlectinibHao Zeng, Yalun Li, Ye Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 23, 2025
[Exploration and Challenge of Whole Course Follow-up Management Model for Small Cell Lung Cancer]Chengming Huang, Yongzhao Zhou, Jing Xu, et al.
Pageof 11